glp 1 receptor agonist for weight loss Top GLP-1 Agonists Balance Efficacy, Safety The GLP-1 Agonists and Obesity:

[1] Dulaglutide (Trulicity): 0.75 mg or 1.5 mg once weekly for type 2 diabetes

95 Lixisenatide is a short-acting GLP-1RA agent, 96,97 and once-daily lixisenatide can improve patient compliance to a certain extent and reduce the occurrence of hypoglycemia

Likewise, first- and second-phase insulin secretion and insulin sensitivity were increased, while postprandial plasma glucose concentrations and plasma glucagon concentrations were lowered

An identical study undertaken across 6 countries evaluated the tolerability of GLP-1 agonists in pregnant women and their effects on fetal outcomes (91)

Exenatide (Byetta) injection [package insert]

This clinical trial did not include patients with T2D, and the emerging data suggests that the weight-loss effects of tirzepatide are reduced in patients with diabetes, a difference also observed in trials with 2.4 mg of semaglutide 2